Scopolamine hydrobromide hydrate

氢溴酸东莨菪碱

Report date: 2023/09/27 17:47:51
NME

Base Information

Drug NameScopolamine hydrobromide hydrate
Drug Alias NameHyoscine HydrobromideHyscoDPI-386
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsCognitive DysfunctionDepressive Disorder, MajorBipolar Disorder +[14] 
Global Approved IndicationsBipolar DisorderPoisoningMotion Sickness +[8] 
Approved Indications in ChinaBipolar DisorderPoisoningMotion Sickness +[6] 
Original Approved Country/TerritoryJapan
Original Approved Date1960/11/01
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Texas Southwestern Medical CenterDefender Pharmaceuticals IncRepurposed Therapeutics Inc +[4] 
Inactive CompaniesBattelle Memorial Institute
Active IndicationsCognitive DysfunctionBipolar DisorderPoisoning +[12] 
Inactive IndicationsDepressive Disorder, MajorOrganophosphate Poisoning

Other Information

ATC CodeA04AD01N05CM05S01FA02
Related LinksWikipediaDrugBankKEGG